Panzhihua, located on the banks of the Jinsha River in the southernmost part of Sichuan Province, is the only city in China named after a flower and is known as the “City of Flower and Flower of City”.
Panzhihua Daguanming Eyewear Co., Ltd. is located in this sunny and flowery city. Founded in 1986, under the leadership of the company’s chairman, Xue Kejun, it has always adhered to strong professional knowledge and a concept of quality service to serve consumers wholeheartedly. After over 30 years of development, its performance has been at the forefront of the same province for many years. Its business not only covers surrounding counties and cities, but also has high popularity and influence in the national optometry industry.
On October 17th, 2021, the Panzhihua Eye Health Public Welfare Summit and Panzhihua Daguanming Eye Clinic Opening Ceremony were held in Panzhihua. Wang Ningli, academician of the International Academy of Ophthalmology and president of Beijing Tongren Eye Center, Xue Kejun, chairman of Panzhihua Daguanming Eyewear Co., Ltd., and Zhang Yue, executive editor-in-chief of Shijie magazine and founder of Yuetoutiao, attended the event.
Professor Wang Ningli highly praised the transformation of Panzhihua Daguanming Eyewear Co., Ltd. and the establishment of an eye clinic. He hopes that the Daguanming Clinic will use more professional technology and services to bring light to more patients with eye diseases.
The achievements of Panzhihua Daguanming Eyewear Co., Ltd. today are inseparable from the forward-looking strategic vision, precise market positioning, and consistent adherence to professional development by Chairman Xue Kejun. From the very beginning, Panzhihua Daguanming has placed great emphasis on inviting well-known ophthalmology experts for consultations and training, introducing advanced ophthalmic professional equipment, strengthening employees’ vision technology and ophthalmic knowledge learning, continuous innovation, and keeping up with the times, allowing the company to steadily advance and develop.
During the visit to Panzhihua Daguanming Eye Clinic, the Big Vision fully automatic artificial intelligence OCT BV1000 attracted everyone’s attention.
Currently, the optometry industry is gradually shifting from traditional eyewear business to the rapid development of vision disease diagnosis and treatment and eye health management. In the trend of vision centers seeking upgrades and transformations, Panzhihua Daguanming once again leads the industry by being the first in the country to introduce Big Vision fully automatic artificial intelligence OCT BV1000, providing strong professional technical support for business development.
In the view of Chairman Xue Kejun, optometrists should not only focus on the user’s vision, but should also play a larger role in eye health management throughout the user’s entire lifecycle, including paying attention to eye fundus lesions caused by high myopia.
Not long ago, Professor Wang Ningli pointed out in an interview with “Healthy China Observer”: “High myopia and pathological myopia can cause some eye diseases, endanger visual health, and even lead to blindness, such as retinal detachment, macular hole, and choroidal neovascularization. Therefore, people with high myopia and pathological myopia should regularly check their fundus throughout their life.”
Many myopic patients choose to undergo corneal laser surgery, but it should be noted that although postoperative vision is improved, the eye fundus structure does not change. Especially for highly myopic patients, due to the elongation of the eye axis and associated eye fundus lesions, these pathological changes still exist after the operation and have not been cured, so regular fundus examinations are still necessary.
In recent years, orthokeratology lenses have become more and more popular among parents and students in the prevention and control of myopia. However, to achieve standardized fitting of orthokeratology lenses, fundus examination must be carried out first to exclude fundus lesions that affect vision function, such as retinal degeneration, edema, and bleeding. Based on its forward-looking understanding of the optometry business, Panzhihua Daguanming made the decision to introduce Big Vision fully automatic artificial intelligence OCT after learning about its trial use.
Big Vision Medical’s new generation of fully automatic artificial intelligence OCT BV1000 perfectly fits the scene requirements of the transformation and upgrade of optometry centers. With automatic pupil positioning and focusing, full-process voice guidance, and a greatly shortened learning curve, operators can quickly become skilled in completing the examination.
The Big Vision Medical BV1000 integrates industry-leading OCT ophthalmic imaging AI algorithms, which can provide diagnostic assistance for 16 major ophthalmic diseases, accurately identify, segment, and automatically label lesion areas, and provide substantial help for the transformation and upgrading of optometry centers and the improvement of diagnosis and treatment levels.
The BV1000 also incorporates Big Vision’s advanced artificial intelligence algorithm for automatic segmentation of the choroid, which can perform automatic segmentation and thickness measurement of the choroid, providing valuable reference for the scientific formulation of myopia intervention measures.
Chairman Xue Kejun attaches great importance to the introduction of fully automatic AI OCT and has specially organized technical backbone personnel to learn OCT knowledge and practical operations. He hopes that every employee can be proficient in OCT operation like they are with optometry equipment, learn OCT well and use it effectively.
We wish Panzhihua Daguanming under the leadership of Chairman Xue will continuously write new chapters in this new journey. Big Vision Medical will also rely on advanced ophthalmic AI, work together with optometrists and ophthalmologists, and contribute greater strength to the cause of sight for the whole society.
No comments yet.